Literature DB >> 26311541

Setleis syndrome due to inheritance of the 1p36.22p36.21 duplication: evidence for lack of penetrance.

Beom Hee Lee1,2, Christos Kasparis3, Brenden Chen1, Hui Mei1, Lisa Edelmann1, Celia Moss3, David D Weaver4, Robert J Desnick1.   

Abstract

Setleis syndrome, focal facial dermal dysplasia type III (FFDD3, MIM #227260), is characterized by scar-like bitemporal lesions and other ocular and facial dysmorphic features. The syndrome results from recessive mutations in the TWIST2 gene, encoding a basic helix-loop-helix transcription factor or de novo genomic duplication or triplication, which include 1.3 Mb at 1p36.22p36.21, or other yet undefined lesions, emphasizing the syndrome's genetic heterogeneity. Recently, three patients were reported with 1p36.22p36.21 duplications/triplication that had the characteristic FFDD3 features and developmental delay or intellectual disabilities. Here, we describe a male with this microduplication, and the typical FFDD3 phenotype, but normal intelligence. Notably, his duplication was inherited from his father who did not have any FFDD3 manifestations, indicating lack of penetrance of the 1p36.22p36.21 microduplication. These findings emphasize phenotypic heterogeneity of the 1p36.22p36.21 copy number variant and the importance of screening the parents of patients with the 1p36.22p36.21 copy number variant to determine whether the duplication/triplication is de novo or inherited, for informed reproductive and genetic counseling.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26311541     DOI: 10.1038/jhg.2015.103

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  19 in total

1.  Setleis syndrome in Mexican-Nahua sibs due to a homozygous TWIST2 frameshift mutation and partial expression in heterozygotes: review of the focal facial dermal dysplasias and subtype reclassification.

Authors:  David E Cervantes-Barragán; Camilo E Villarroel; Alma Medrano-Hernández; Carola Durán-McKinster; Vanessa Bosch-Canto; Victoria Del-Castillo; Irina Nazarenko; Amy Yang; Robert J Desnick
Journal:  J Med Genet       Date:  2011-10       Impact factor: 6.318

Review 2.  Monosomy 1p36.

Authors:  A Slavotinek; L G Shaffer; S K Shapira
Journal:  J Med Genet       Date:  1999-09       Impact factor: 6.318

3.  Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis.

Authors:  L Li; P Cserjesi; E N Olson
Journal:  Dev Biol       Date:  1995-11       Impact factor: 3.582

4.  Focal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1.

Authors:  Anne M Slavotinek; Pavni Mehrotra; Irina Nazarenko; Paul Ling-Fung Tang; Richard Lao; Don Cameron; Ben Li; Catherine Chu; Chris Chou; Ann L Marqueling; Mani Yahyavi; Kelly Cordoro; Ilona Frieden; Tom Glaser; Trine Prescott; Marie-Anne Morren; Koen Devriendt; Pui-yan Kwok; Martin Petkovich; Robert J Desnick
Journal:  Hum Mol Genet       Date:  2012-11-16       Impact factor: 6.150

5.  Complex autism spectrum disorder in a patient with a 17q12 microduplication.

Authors:  Tracy Brandt; Khyati Desai; David Grodberg; Lakshmi Mehta; Ninette Cohen; Ana Tryfon; Alexander Kolevzon; Latha Soorya; Joseph D Buxbaum; Lisa Edelmann
Journal:  Am J Med Genet A       Date:  2012-04-04       Impact factor: 2.802

6.  Homozygous nonsense mutations in TWIST2 cause Setleis syndrome.

Authors:  Turgut Tukel; Drazen Šošić; Lihadh I Al-Gazali; Mónica Erazo; Jose Casasnovas; Hector L Franco; James A Richardson; Eric N Olson; Carmen L Cadilla; Robert J Desnick
Journal:  Am J Hum Genet       Date:  2010-08-13       Impact factor: 11.025

7.  A 15q24 microduplication, reciprocal to the recently described 15q24 microdeletion, in a boy sharing clinical features with 15q24 microdeletion syndrome patients.

Authors:  Ann-Britt Kiholm Lund; Hanne Dahlgaard Hove; Maria Kirchhoff
Journal:  Eur J Med Genet       Date:  2008-08-07       Impact factor: 2.708

8.  Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities.

Authors:  Nicola Brunetti-Pierri; Jonathan S Berg; Fernando Scaglia; John Belmont; Carlos A Bacino; Trilochan Sahoo; Seema R Lalani; Brett Graham; Brendan Lee; Marwan Shinawi; Joseph Shen; Sung-Hae L Kang; Amber Pursley; Timothy Lotze; Gail Kennedy; Susan Lansky-Shafer; Christine Weaver; Elizabeth R Roeder; Theresa A Grebe; Georgianne L Arnold; Terry Hutchison; Tyler Reimschisel; Stephen Amato; Michael T Geragthy; Jeffrey W Innis; Ewa Obersztyn; Beata Nowakowska; Sally S Rosengren; Patricia I Bader; Dorothy K Grange; Sayed Naqvi; Adolfo D Garnica; Saunder M Bernes; Chin-To Fong; Anne Summers; W David Walters; James R Lupski; Pawel Stankiewicz; Sau Wai Cheung; Ankita Patel
Journal:  Nat Genet       Date:  2008-12       Impact factor: 38.330

9.  Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients.

Authors:  Regina E Ensenauer; Adewale Adeyinka; Heather C Flynn; Virginia V Michels; Noralane M Lindor; D Brian Dawson; Erik C Thorland; Cindy Pham Lorentz; Jennifer L Goldstein; Marie T McDonald; Wendy E Smith; Elba Simon-Fayard; Alan A Alexander; Anita S Kulharya; Rhett P Ketterling; Robin D Clark; Syed M Jalal
Journal:  Am J Hum Genet       Date:  2003-10-02       Impact factor: 11.025

10.  Detection of low-level mosaicism and placental mosaicism by oligonucleotide array comparative genomic hybridization.

Authors:  Stuart A Scott; Ninette Cohen; Tracy Brandt; Gokce Toruner; Robert J Desnick; Lisa Edelmann
Journal:  Genet Med       Date:  2010-02       Impact factor: 8.822

View more
  2 in total

1.  Focal facial dermal dysplasia type 4: identification of novel CYP26C1 mutations in unrelated patients.

Authors:  Beom Hee Lee; Fanny Morice-Picard; Franck Boralevi; Brenden Chen; Robert J Desnick
Journal:  J Hum Genet       Date:  2017-12-20       Impact factor: 3.172

2.  Expression Profiling Identifies TWIST2 Target Genes in Setleis Syndrome Patient Fibroblast and Lymphoblast Cells.

Authors:  Noe E Crespo; Alexandra Torres-Bracero; Jessicca Y Renta; Robert J Desnick; Carmen L Cadilla
Journal:  Int J Environ Res Public Health       Date:  2021-02-19       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.